Intellectual Property India Publishes Patent Application for 'Dosing And Scheduling Regimen For Broadly Neutralizing Antibodies' Filed by Gilead Sciences Inc.

MUMBAI, India, May 16 -- Intellectual Property India has published a patent application (202517021242 A) filed by Gilead Sciences Inc., Foster City, U.S.A., on March 10, for 'dosing and scheduling regimen for broadly neutralizing antibodies.'

Inventor(s) include Zheng Yanan; Cihlar Tomas; and Brainard Diana M.

The application for the patent was published on May 16, under issue no. 20/2025.

According to the abstract released by the Intellectual Property India: "Provided are methods for administering long acting anti HIV broadly neutralizing antibodies twice annually e.g. Q6M Q24W Q25W or Q26W."

The patent application was internationally filed on Aug. 11, 2023, under International application No.PCT/US2023/072098.

Disclaimer: Curated by ...